Kim Jihye, Park Minjung, Sung Angela Dong-Min, Kim Kyeong Han, Sung Soo-Hyun
Research Institute of Korean Medicine Policy, The Association of Korean Medicine, Seoul, Republic of Korea.
National Agency for Development of Innovative Technologies in Korean Medicine, Seoul, Republic of Korea.
J Pharmacopuncture. 2020 Dec 31;23(4):252-261. doi: 10.3831/KPI.2020.23.4.252.
Chronic diseases (CDs) continue to increase due to advances in medicine and increase in lifespan, affecting quality of life and resulting in economic loss through treatment costs. This study addressed the perception characteristics of the effectiveness of Korean medicine (KM) based on the existence of a CD to determine the national preference for KM treatment.
Using data from the 2017 National Survey of KM Usage, we evaluated the perception on treatment effect of 16 diseases by dividing them into the CD group and the non-CD group. Response reliability was verified by applying the chi-square test (χ-test) analysis method of the Statistical Package for the Social Sciences (SPSS) statistical program.
The analysis of the perception on effectiveness of KM for patients with CD (n = 1,050, 21.0%) and for patients with non-CD (n = 3,950, 79.0%) showed an overall similar trend for all the 16 diseases. The response rates of having some treatment effect were high for nine diseases namely, disc-related disease (CD 70.7%, non-CD 73.1%), osteoarthritis (CD 72.3%, non-CD 72.4%), frozen shoulder and shoulder pain (CD 79.6%, non-CD 81.4%), back pain (CD 84.6%, non-CD 85.0%), sprain (CD 84.8%, non-CD 84.1%), facial nerve paralysis (CD 73.5%, non-CD 71.7%), stroke (CD 66.2%, non-CD 62.8%), digestive disease (CD 53.3%, non-CD 50.0%), and common cold and rhinitis (CD 44.7%, non-CD 44.8%).
The present results found that there was little difference in the perception on effectiveness of KM for each of the 16 diseases in patients with CD and non-CD, however, 70% or more of the respondents recognized some treatment effect on musculoskeletal disorders, regardless of the existence of CD. Preferential political support for KM treatment of chronic musculoskeletal disorders is recommended.
由于医学进步和寿命延长，慢性病（CDs）持续增加，影响生活质量并因治疗费用导致经济损失。本研究基于是否患有慢性病来探讨韩医学（KM）疗效的认知特征，以确定国民对韩医学治疗的偏好。
利用2017年全国韩医学使用情况调查的数据，我们将16种疾病分为慢性病组和非慢性病组，评估了对这些疾病治疗效果的认知。通过应用社会科学统计软件包（SPSS）统计程序的卡方检验（χ检验）分析方法来验证回答的可靠性。
对患有慢性病的患者（n = 1050，21.0%）和非慢性病患者（n = 3950，79.0%）对韩医学疗效的认知分析表明，所有16种疾病的总体趋势相似。九种疾病有一定治疗效果的应答率较高，分别为椎间盘相关疾病（慢性病组70.7%，非慢性病组73.1%）、骨关节炎（慢性病组72.3%，非慢性病组72.4%）、肩周炎和肩部疼痛（慢性病组79.6%，非慢性病组81.4%）、背痛（慢性病组84.6%，非慢性病组85.0%）、扭伤（慢性病组84.8%，非慢性病组84.1%）、面神经麻痹（慢性病组73.5%，非慢性病组71.7%）、中风（慢性病组66.2%，非慢性病组62.8%）、消化系统疾病（慢性病组53.3%，非慢性病组50.0%）以及普通感冒和鼻炎（慢性病组44.7%，非慢性病组44.8%）。
目前的结果发现，患有慢性病和未患慢性病的患者对16种疾病中每种疾病的韩医学疗效认知差异不大，然而，无论是否患有慢性病，70%或更多的受访者认可对肌肉骨骼疾病有一定治疗效果。建议对慢性肌肉骨骼疾病的韩医学治疗给予优先政策支持。
